Curtiss-Wright R&D decreased by 4.9% to $24.18M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 5.1%, from $23.02M to $24.18M. Over 4 years (FY 2021 to FY 2025), R&D shows relatively stable performance with a 1.8% CAGR.
Analysis
StatementIncome Statement
SectionOperating Expenses
CategoryGrowth
SignalContext dependent
VolatilityModerate
First reportedQ1 2014
Last reportedQ1 2026
How to read this metric
Higher spending signals a commitment to innovation and future product launches, whereas significant cuts may indicate a shift toward short-term profitability.
Detailed definition
Research and development expenses represent the costs incurred to discover new products, improve existing technologies,...
Peer comparison
Highly comparable across pharmaceutical and medical device peers, where R&D intensity is a key metric for long-term valuation.
Metric ID:
research_and_developmentHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $23.19M | $21.62M | $21.81M | $20.55M | $23.87M | $17.39M | $19.03M | $22.02M | $20.21M | $23.46M | $20.07M | $22.98M | $22.15M | $20.73M | $25.78M | $23.02M | $23.31M | $23.41M | $25.43M | $24.18M |
| QoQ Change | — | -6.8% | +0.9% | -5.8% | +16.2% | -27.2% | +9.5% | +15.7% | -8.2% | +16.1% | -14.5% | +14.5% | -3.6% | -6.4% | +24.3% | -10.7% | +1.3% | +0.4% | +8.6% | -4.9% |
| YoY Change | — | — | — | — | +2.9% | -19.6% | -12.8% | +7.2% | -15.3% | +35.0% | +5.4% | +4.3% | +9.6% | -11.6% | +28.5% | +0.2% | +5.2% | +12.9% | -1.4% | +5.1% |
Range$17.39M – $25.78M
CAGR+0.9%
Avg YoY Growth+3.5%
Median YoY Growth+4.7%
R&D at Other Companies
Frequently Asked Questions
- What is Curtiss-Wright's r&d?
- Curtiss-Wright (CW) reported r&d of $24.18M in Q1 2026.
- How has Curtiss-Wright's r&d changed year-over-year?
- Curtiss-Wright's r&d increased by 5.1% year-over-year, from $23.02M to $24.18M.
- What is the long-term trend for Curtiss-Wright's r&d?
- Over 4 years (2021 to 2025), Curtiss-Wright's r&d has grown at a 1.8% compound annual growth rate (CAGR), from $88.49M to $95.16M.
- What does r&d mean?
- The money spent on creating new products or improving existing ones to drive future growth.